Compare
Criteo S.A. vs Haoxi Health Technology Ltd
| Latest fiscal year | Criteo S.A. CRTO | Haoxi Health Technology Ltd HAO |
|---|---|---|
| Year ended | 2025-12-31 | 2026-06-30 |
| Revenue | $1.94B | $54.83M |
| Revenue growth (YoY) | +0.6% | +67.1% |
| Gross margin | 54.0% | 1.1% |
| Operating margin | 10.4% | -17.6% |
| Net margin | 7.4% | -17.4% |
| Net income | $144.60M | -$9.54M |
| EPS (Diluted) | $2.64 | -$386.40 |
| Operating cash flow | $311.24M | -$2.57M |
| Free cash flow | $208.50M | n/a |
| Cash & equivalents | $342.04M | $10.93M |
| Total assets | $2.20B | $21.57M |
| Total liabilities | $1.02B | $3.71M |
| Shareholders' equity | $1.19B | $17.86M |
| Return on year-end equity | 12.2% | -53.4% |
| Shares outstanding | 51.15M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Criteo S.A. | Haoxi Health Technology Ltd |
|---|---|---|
| Latest | $1.94B Ended 2025-12-31 | $54.83M Ended 2026-06-30 |
| 1 year earlier | $1.93B Ended 2024-12-31 | $32.80M Ended 2025-06-30 |
| 2 years earlier | $1.95B Ended 2023-12-31 | $48.52M Ended 2024-06-30 |
| 3 years earlier | $2.02B Ended 2022-12-31 | $28.23M Ended 2023-06-30 |
| 4 years earlier | $2.25B Ended 2021-12-31 | $16.16M Ended 2022-06-30 |